BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Yusuke Sasaki, Masato Asahiyama, Toshiya Tanaka, Shogo Yamamoto, Kentaro Murakami, Wakana Kamiya, Yoshihiro Matsumura, Tsuyoshi Osawa, Motonobu Anai, Jean-Charles Fruchart, Hiroyuki Aburatani, Juro Sakai, Tatsuhiko Kodama. Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride contentScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-64902-8
2
Alice Y. Chen-Liaw, Gabrielle Hammel, George Gomez. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cellsIn Vitro Cellular & Developmental Biology - Animal 2017; 53(8): 721 doi: 10.1007/s11626-017-0181-y
3
Prajakta C. Shimpi, Vijay R. More, Maneesha Paranjpe, Ajay C. Donepudi, Jaclyn M. Goodrich, Dana C. Dolinoy, Beverly Rubin, Angela L. Slitt. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver DiseaseEnvironmental Health Perspectives 2017; 125(8): 087005 doi: 10.1289/EHP664
4
Peter B. Soeters, Peter W. de Leeuw. Reciprocal Translation Between Pathophysiology and Practice in Health and Disease2021; : 93 doi: 10.1016/B978-0-12-820205-0.00002-5
5
Fenghua Li, Yang Yang, Lili Yang, Kai Wang, Xing Zhang, Yunlong Zong, Yixin Ding, Changhong Wang, Li Zhang, Guang Ji. Resveratrol alleviates FFA and CCl4 induced apoptosis in HepG2 cells via restoring endoplasmic reticulum stressOncotarget 2017; 8(27): 43799 doi: 10.18632/oncotarget.16460
6
Willem van den Brink, Robbert Bloem, Adithya Ananth, Thiru Kanagasabapathi, Arjen Amelink, Jildau Bouwman, Gerwin Gelinck, Sjaak van Veen, Andre Boorsma, Suzan Wopereis. Digital Resilience Biomarkers for Personalized Health Maintenance and Disease PreventionFrontiers in Digital Health 2021; 2 doi: 10.3389/fdgth.2020.614670
7
Emmanuelle Berger, Alain Géloën. Adipocytes as lipid sensors of oleic acid transport through a functional Caco-2/HT29-MTX intestinal barrierAdipocyte 2019; 8(1): 83 doi: 10.1080/21623945.2019.1580842
8
Weilei Yao, Tongxin Wang, Jun Xia, Juan Li, Xinhong Yu, Feiruo Huang. Dietary Garcinol Attenuates Hepatic Pyruvate and Triglyceride Accumulation by Inhibiting P300/CBP-Associated Factor in Mid-to-Late Pregnant RatsThe Journal of Nutrition 2019;  doi: 10.1093/jn/nxz238
9
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An updateMetabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
10
Yu Yuan Li, Dan Tang, Yan Lei Du, Chuang Yu Cao, Yu Qiang Nie, Jie Cao, Yong Jian Zhou. Fatty liver mediated by peroxisome proliferator-activated receptor-α DNA methylation can be reversed by a methylation inhibitor and curcuminJournal of Digestive Diseases 2018; 19(7): 421 doi: 10.1111/1751-2980.12610
11
Shulun Jiang, Di-an Fang, Dongpo Xu. Transcriptome analysis of Takifugu obscurus liver in response to acute retene exposureJournal of Environmental Science and Health, Part A 2020; 55(10): 1188 doi: 10.1080/10934529.2020.1780852
12
Tyler A. Shaw, Ragunath Singaravelu, Megan H. Powdrill, Jordan Nhan, Nadine Ahmed, Dennis Özcelik, John Paul Pezacki. MicroRNA-124 Regulates Fatty Acid and Triglyceride HomeostasisiScience 2018; 10: 149 doi: 10.1016/j.isci.2018.11.028
13
Sadia Qamar Arain, Farah Naz Talpur, Naseem Aslam Channa, Muhammad Shahbaz Ali, Hassan Imran Afridi. Serum lipids as an indicator for the alteration of liver function in patients with hepatitis BLipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0683-y
14
Jeongin Yoo, Jeong Min Lee, Ijin Joo, Dong Ho Lee, Jeong Hee Yoon, Hyo-Jin Kang, Su Joa Ahn. Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosisUltrasonography 2020; 39(2): 121 doi: 10.14366/usg.19034
15
Weining Xie, Shengxin Chen. A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese populationMedicine 2020; 99(48): e23049 doi: 10.1097/MD.0000000000023049
16
A. I. Ershova, D. O. Al Rashi, A. A. Ivanova, Yu. O. Aksenova, A. N. Meshkov. Secondary hyperlipidemias: etiology and pathogenesisRussian Journal of Cardiology 2019; (5): 74 doi: 10.15829/1560-4071-2019-5-74-81
17
Abbas Ali Sangouni, Saeid Ghavamzadeh, Atena Jamalzehi. A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver DiseaseDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 2260 doi: 10.1016/j.dsx.2019.05.013
18
Vesna Lukenda Zanko, Viktor Domislovic, Vladimir Trkulja, Irena Krznaric‐Zrnic, Tamara Turk‐Wensveen, Zeljko Krznaric, Tajana Filipec Kanizaj, Delfa Radic‐Kristo, Lidija Bilic‐Zulle, Lidija Orlic, Petra Dinjar‐Kujundzic, Goran Poropat, Davor Stimac, Goran Hauser, Ivana Mikolasevic. Vitamin D for treatment of non‐alcoholic fatty liver disease detected by transient elastography: A randomized, double‐blind, placebo‐controlled trialDiabetes, Obesity and Metabolism 2020; 22(11): 2097 doi: 10.1111/dom.14129
19
Hee-Sook Lim, Joungyun Choi, Bora Lee, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo. Association between Inflammatory Biomarkers and Nutritional Status in Fatty LiverClinical Nutrition Research 2020; 9(3): 182 doi: 10.7762/cnr.2020.9.3.182
20
Yu-Yuan Li, Chuang-Yu Cao, You-lian Zhou, Yu-Qiang Nie, Jie Cao, Yong-Jian Zhou. The roles and interaction of FXR and PPARs in the pathogenesis of nonalcoholic fatty liver diseaseArab Journal of Gastroenterology 2020; 21(3): 162 doi: 10.1016/j.ajg.2020.04.018
21
Pavel Kraml. Lipid-lowering therapy in selected specific groups of patientsMedicína pro praxi 2020; 17(3): 151 doi: 10.36290/med.2020.029
22
Xiaorui Yao, Fan Xia, Waijiao Tang, Chunxin Xiao, Miaoting Yang, Benjie Zhou. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in ratsJournal of Ethnopharmacology 2018; 212: 208 doi: 10.1016/j.jep.2017.09.016
23
Pratima Dibba, Rosann Cholankeril, Andrew Li, Meera Patel, Mariam Fayek, Christy Dibble, Nnenna Okpara, Autumn Hines, Aijaz Ahmed. Hepatitis C in PregnancyDiseases 2018; 6(2): 31 doi: 10.3390/diseases6020031
24
Maxim Jestin, Senta M. Kapnick, Tatyana N. Tarasenko, Cassidy T. Burke, Patricia M. Zerfas, Francisca Diaz, Hilary Vernon, Larry N. Singh, Ronald J. Sokol, Peter J. McGuire. Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicityMolecular Metabolism 2020; 37: 100981 doi: 10.1016/j.molmet.2020.100981
25
Grietje Prins, Theerut Luangmonkong, Dorenda Oosterhuis, Henricus Mutsaers, Frank Dekker, Peter Olinga. A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver SlicesNutrients 2019; 11(3): 507 doi: 10.3390/nu11030507
26
Umar Farooque, Ashok Kumar Lohano, Quratulain Dahri, Nazia Arain, FNU Farukhuddin, Chinmay Khadke, Febin Prince, Rizwan Farooque, Mostafa A Shehata, Muhammad Daim Bin Zafar. The Pattern of Dyslipidemia in Chronic Liver Disease PatientsCureus 2021;  doi: 10.7759/cureus.13259
27
Dong-Woo Lim, Hyuck Kim, Seung-Jun Lee, Ga-Ram Yu, Jai-Eun Kim, Won-Hwan Park. Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling PathwayEvidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4589810
28
Kenneth Leung, Michael Quezada, Zhengshan Chen, Gary Kanel, Neil Kaplowitz. Niacin‐Induced Anicteric Microvesicular Steatotic Acute Liver FailureHepatology Communications 2018; 2(11): 1293 doi: 10.1002/hep4.1253
29
Bojan Jorgačević, Danijela Vučević, Ivana Đuričić, Slađana Šobajić, Dušan Mladenović, Milena Vesković, Rada Ješić Vukićević, Tatjana Radosavljević. The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver diseaseChemistry and Physics of Lipids 2017; 204: 85 doi: 10.1016/j.chemphyslip.2017.03.009
30
Myoung Ki Cho, Min Ji Seo, Vinayak Juvekar, Jae Hyung Jo, Wontae Kim, Kyeong Sook Choi, Hwan Myung Kim. Screening of Drug-Induced Steatosis and Phospholipidosis Using Lipid Droplet-Selective Two-Photon ProbesAnalytical Chemistry 2020; 92(16): 11223 doi: 10.1021/acs.analchem.0c01728
31
Ben van Ommen, Tim van den Broek, Iris de Hoogh, Marjan van Erk, Eugene van Someren, Tanja Rouhani-Rankouhi, Joshua C Anthony, Koen Hogenelst, Wilrike Pasman, André Boorsma, Suzan Wopereis. Systems biology of personalized nutritionNutrition Reviews 2017; 75(8): 579 doi: 10.1093/nutrit/nux029
32
Karen R. Jonscher, Kimberley D. Bruce. Reviews on Biomarker Studies of Metabolic and Metabolism-Related DisordersAdvances in Experimental Medicine and Biology 2019; 1134: 33 doi: 10.1007/978-3-030-12668-1_3
33
Sang Hyun Ahn, Kang Pa Lee, Kibong Kim, Jun-Yong Choi, Sun-Young Park, Jin Hong Cheon. Dansameum regulates hepatic lipogenesis and inflammation in vitro and in vivoFood Science and Biotechnology 2019; 28(5): 1543 doi: 10.1007/s10068-019-00579-8
34
Rihua Zhang, Jing Bao Kan, Shan Lu, Pei Tong, Jie Yang, Ling Xi, Xiubing Liang, Dongming Su, Dong Li, Yun Liu. S100A16-induced adipogenesis is associated with up-regulation of 11 β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)Bioscience Reports 2019; 39(9) doi: 10.1042/BSR20182042
35
Nannan Zhao, Shu Yang, Yimin Jia, Bo Sun, Bin He, Ruqian Zhao. Maternal betaine supplementation attenuates glucocorticoid-induced hepatic lipid accumulation through epigenetic modification in adult offspring ratsThe Journal of Nutritional Biochemistry 2018; 54: 105 doi: 10.1016/j.jnutbio.2017.12.003
36
Xiao-qun Han, San-qing Xu, Jian-guo Lin. Curcumin Recovers Intracellular Lipid Droplet Formation Through Increasing Perilipin 5 Gene Expression in Activated Hepatic Stellate Cells In VitroCurrent Medical Science 2019; 39(5): 766 doi: 10.1007/s11596-019-2104-5
37
Reem Ghazali, Kosha J Mehta, SW Annie Bligh, Ihab Tewfik, Dahn Clemens, Vinood B Patel. High omega arachidonic acid/docosahexaenoic acid ratio induces mitochondrial dysfunction and altered lipid metabolism in human hepatoma cellsWorld Journal of Hepatology 2020; 12(3): 84-98 doi: 10.4254/wjh.v12.i3.84
38
Abbas Ali Sangouni, Saeid Ghavamzadeh. A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approachDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(5): 2917 doi: 10.1016/j.dsx.2019.07.063
39
Ying Wang, Yao Zhu, Junxing Niu, Qiangqiang Deng, Shimeng Guo, Haowen Jiang, Zhaoliang Peng, Yaru Xue, Huige Peng, Lijiang Xuan, Guoyu Pan. A novel bile acid analog, A17, ameliorated non-alcoholic steatohepatitis in high-fat diet-fed hamstersToxicology and Applied Pharmacology 2020; 404: 115169 doi: 10.1016/j.taap.2020.115169
40
David Grünig, Urs Duthaler, Stephan Krähenbühl. Effect of Toxicants on Fatty Acid Metabolism in HepG2 CellsFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00257
41
Patricia E. Molina. Mechanisms Involved in Disruption of Adipose Tissue Mass Resulting from Chronic Unhealthy Alcohol ConsumptionAlcoholism: Clinical and Experimental Research 2016; 40(11): 2296 doi: 10.1111/acer.13219
42
Johanna Matilainen, Anne-Mari Mustonen, Kirsi Rilla, Reijo Käkelä, Sanna P. Sihvo, Petteri Nieminen. Orotic acid-treated hepatocellular carcinoma cells resist steatosis by modification of fatty acid metabolismLipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01243-5